Update on the Phase 4 Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 201.82 -1.13 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.95 | 52 Week High | $333.65 | |||
| Open | $203.34 | 52 Week Low | $223.02 | |||
| Day High | $203.85 | P/E | 25.84 | |||
| Day Low | $199.58 | EPS | $7.81 | |||
| Volume | 940,857 | |||||

